Abstract
INTRODUCTION:Migraine and tension type headache are the most frequent primary headaches in the medical practice; the clinical improvement of the patients is related to the education carry out by his physician and the prescription of prophylactic treatments. Migraine and tension-type headache are the most frequent primary headaches in the medical office; the clinical improvement of the patients is related to the education provided and the prescription of prophylactic treatments by their treating doctors.
OBJECTIVE:To determine the frequency of prescription of prophylactic treatment and of educational explanations to the patient with primary headache by primary care physicians, and the possible factors associated with them.
MATERIALS AND METHODS:Cross-sectional study with 152 patients that have Migraine or Tensional Headache according to the ICHD criteria and that had an indication for prophylactic treatment according to the Canadian guidelines for the prophylaxis management of patients with migraine, which were attended by primary care physicians. Application of a questionnaire to establish the type of practices carried out by professionals; an univariate and bivariate analysis was performed.
RESULTS:56 °% of the patients never received an educational explanation about their disease, 70 °% had never been referred to a neurology consultation previously, and 23 % had been prescribed prophylactic treatment. 44 °% answered not knowing about the origin of the headache and found a significant association between the educational level of the patient and the fact that they offered educational explanation.
CONCLUSION:The frequency of formulation of pharmacological prophylaxis and the performance of educational explanations to the patient by the Primary Care Physician was very low; This may be related to a lack of knowledge of management protocols in primary headache and to flaws in the clinical skills previously obtained in undergraduate training.
References
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;(27):193-210.
Schramm SH, Obermann M, Katsarava Z, Diener HC, Moebus S, Yoon MS. Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain. 2013;14:40.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59.
Bendtsen L, Evers S, Linde M, Mitsikostas DD. EFNS guideline on the treatment of tension type headache. Eur J Neurol. 2010;17(11):1318-25.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193-210.
Baron EP, Markowitz SY, Lettich A, Hastriter E, Lovell B, Kalidas K, et al. Triptan education and improving knowledge for optimal migraine treatment: An observational study. Headache. 2014;54(4):686-97.
Giacomozzi AR, Vindas AP, da-Silva-Junior AA, Bordini CA, Buonanotte CF, Roesler CA, et al. Consenso Latinoamericano para las Directrices de Tratamiento de la Migraña Crónica. Headache Med. 2012;23(4):162-72.
Medrano-Martínez V, Callejo-Domínguez JM, Beltrán-Lasco I, Pérez-Carmona N, Abellán-Miralles I, González-Caballero G, et al. Folletos de información educativa en migraña: Satisfacción percibida en un grupo de pacientes. Neurología. 2015;30(8):472-89.
Buse DC, Lipton RB. Global perspectives on the burden of episodic and chronic migraine. Cephalalgia. 2013;33(11):885-90.
MacGregor EA. The doctor and the migraine patient: Improving compliance. Neurology. 2012;48(3):16S-20S.
Oleen J, Bendtsen L, Ducros A, Evers S, First M, Goadsby P, et al. The international classification of headache disorders, 3rd edition. Cephalalgia. 2013;33(9):629-808.
Pringsheim T, Davenport W Mackie G, Worthington L, Aube M, Christie SN. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Supl. 2):S1-59.
Constance KC, Jana B, Drew , Sharon EW, John AB, Francis J, et al. Perceptions and needs of patients with migraine. J Fam Pr. 2002;51(2):142-7.
Lipton RB, Stewart WF. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache J Head Face Pain. 2004;39(Supl. 2): S20-6.
Buse DC, Rupnow MFT, Lipton RB. Assessing and managing all aspects of migraine: Migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422-35.
Peters M, Huijer-Abu-Saad H, Vydelingum V, Dowson A, Murphy M. The patients' perceptions of migraine and chronic daily headache: A qualitative study. J Headache Pain. 2005;6(1):40-7.
Lipton RBSWF, von-Korff M. Burden of migraine: Societal costs and therapeutic opportunities. Neurology. 2012;48(3 Supl. 3):S4-9.
Silva-Néto RP, James K, Neri S. Analysis of the duration of migraine prophylaxis. J Neurol Sci. 2014;337(1-2):38-41.
Bhoi SK, Kalita J, Misra UK. Is 6 months of migraine prophylaxis adequate? Neurol Res. 2013;35(10):1009-14.
Sobrino F. Chronic daily headache. Acta Neurol Colomb. 2013;29(1):96-106.
Muñoz J. Tratamiento preventivo para la migraña. Acta Neurol Colomb. 2013;29(1):43-50.
Smelt AFH, Eijsenga SJ, Assendelft WJJ, Blom JW. Acceptance of preventive treatment in migraine patients: Results of a survey. Eur J Gen Pract. 2012;18(3):143-8.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.